WHO ICTRP trial
The effect of Bisoprolol and Verapamil in non-obstructive hypertrophic…
EUCTR2021-006953-77-DK · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2021-006953-77-DK |
|---|---|
| Public title | The effect of Bisoprolol and Verapamil in non-obstructive hypertrophic cardiomyopathy |
| Scientific title | Treatment effects of Bisoprolol and Verapamil in symptomatic patients with non-obstructive hypertrophic cardiomyopathy - TEMPO II |
| Primary sponsor | Aarhus University Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Denmark |
| Conditions | Non-obstructive Hypertrophic cardiomyopathy MedDRA version: 20.0 Level: PT Classification code 10007636 Term: Cardiomyopathy System Organ Class: 10007541 - Cardiac disorders MedDRA version: 20.0 Level: PT Classification code 10049813 Term… |
| Interventions | Trade Name: Bisoprolol Pharmaceutical Form: Modified-release tablet INN or Proposed INN: BISOPROLOL CAS Number: 66722-44-9 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 2.5- Pharmaceutical form of the… |
| Registration date | Jan 31, 2022 |
| Target size | 140 |
| Secondary IDs | 27-12-2021 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: